We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Nanospectra Biosciences, Inc. Names John Stroh New CEO

News   Aug 09, 2011

 
Nanospectra Biosciences, Inc. Names John Stroh New CEO
 
 
 

RELATED ARTICLES

A Possible Reason Why Some Drugs Are Ineffective in Colorectal Cancer

News

A certain group of cancer drugs (MEK Inhibitors) activate the cancer-promoting Wnt signaling pathway in colorectal cancer cells. The findings suggest a possible explanation for why these drugs are not effective in colorectal cancer.

READ MORE

Preventable Cancer Burden Linked to Poor Diet in the U.S. Says Study

News

A new study estimates that 5.2 percent of new invasive cancer cases reported in 2015 are associated with poor diets.

READ MORE

Proton Therapy for Cancer Reduces Risk of Side Effects

News

A new study found that proton therapy is associated with fewer severe side effects than conventional X-ray radiation therapy.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE